{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:25:31Z","timestamp":1791318331049,"version":"4.3.1"},"reference-count":110,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The antineoplastic effects of cannabis have been known since 1975. Since the identification of the components of the endogenous cannabinoid system (ECS) in the 1990s, research into the potential of cannabinoids as medicine has exploded, including in anti-cancer research. However, nearly all of this research has been on adults. Physicians and governing bodies remain cautious in recommending the use of cannabis in children, since the ECS develops early in life and data about cannabis exposure in utero show negative outcomes. However, there exist many published cases of use of cannabis in children to treat pediatric epilepsy and chemotherapy-induced nausea and vomiting (CINV) that show both the safety and efficacy of cannabis in pediatric populations. Additionally, promising preclinical evidence showing that cannabis has anti-cancer effects on pediatric cancer warrants further investigation of cannabis\u2019 use in pediatric cancer patients, as well as other populations of pediatric patients. This review aims to examine the evidence regarding the potential clinical utility of cannabis as an anti-cancer treatment in children by summarizing what is currently known about uses of medical cannabis in children, particularly regarding its anti-cancer potential.<\/jats:p>","DOI":"10.3390\/ph15030359","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T22:15:04Z","timestamp":1647468904000},"page":"359","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Medical Cannabis in Pediatric Oncology: Friend or Foe?"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-1997","authenticated-orcid":false,"given":"Megan","family":"Malach","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K3M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Kovalchuk","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K3M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kovalchuk","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K3M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"ref_1","unstructured":"(2021, November 06). Cancer in Children and Adolescents, Available online: https:\/\/www.cancer.gov\/types\/childhood-cancers\/child-adolescent-cancers-fact-sheet."},{"key":"ref_2","unstructured":"(2021, November 05). Childhood Cancer Statistics. Available online: http:\/\/www.cancer.ca\/en\/cancer-information\/cancer-101\/childhood-cancer-statistics\/?region=on."},{"key":"ref_3","unstructured":"Pizzo, P.A., and Poplack, D.G. (2016). Chapter 48\u2014Late Effects of Childhood Cancer and its Treatment. Principles and Practice of Pediatric Oncology, Lippincott Williams & Wilkins. [7th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1503\/cmaj.191292","article-title":"Projected estimates of cancer in Canada in 2020","volume":"192","author":"Brenner","year":"2020","journal-title":"Can. Med. Assoc. J. (CMAJ)"},{"key":"ref_5","unstructured":"American Cancer Society (2021, November 05). Cancer Facts & Figures 2020. Available online: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2020.html."},{"key":"ref_6","unstructured":"Pizzo, P.A., and Poplack, D.G. (2016). Chapter 1\u2014Epidemiology of Childhood Cancer. Principles and Practice of Pediatric Oncology, Lippincott Williams & Wilkins. [7th ed.]."},{"key":"ref_7","unstructured":"Pizzo, P.A., and Poplack, D.G. (2016). Chapter 4\u2014The Biology of Childhood Cancer. Principles and Practice of Pediatric Oncology, Lippincott Williams & Wilkins. [7th ed.]."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ng.2287","article-title":"The Pediatric Cancer Genome Project","volume":"44","author":"Downing","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Worst","year":"2018","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1038\/ncomms4630","article-title":"The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes","volume":"5","author":"Huether","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline Mutations in Predisposition Genes in Pediatric Cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_12","first-page":"S23","article-title":"Disposition of antineoplastic agents in the very young child","volume":"18","author":"McLeod","year":"1992","journal-title":"Br. J. Cancer Suppl."},{"key":"ref_13","unstructured":"Pizzo, P.A., and Poplack, D.G. (2016). Chapter 10\u2014General Principles of Chemotherapy. Principles and Practice of Pediatric Oncology, Lippincott Williams & Wilkins. [7th ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"740673","DOI":"10.1155\/2011\/740673","article-title":"High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: A single institution experience from UCLA","volume":"2011","author":"Panosyan","year":"2011","journal-title":"J. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/cncr.23305","article-title":"High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors","volume":"112","author":"Shih","year":"2008","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/pbc.24665","article-title":"Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors","volume":"60","author":"Brown","year":"2013","journal-title":"Pediatric Blood Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pbc.22318","article-title":"Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: An analysis of the Head Start II survivors","volume":"54","author":"Sands","year":"2010","journal-title":"Pediatric Blood Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3322\/caac.21219","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA A Cancer J. Clin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/pbc.24487","article-title":"Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors","volume":"60","author":"Green","year":"2013","journal-title":"Pediatric Blood Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/pbc.23385","article-title":"Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies","volume":"58","author":"Hudson","year":"2012","journal-title":"Pediatric Blood Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc3634","article-title":"Survivors of childhood and adolescent cancer: Life-long risks and responsibilities","volume":"14","author":"Robison","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/15384101.2017.1334022","article-title":"Chemo brain: From discerning mechanisms to lifting the brain fog\u2014An aging connection","volume":"16","author":"Kovalchuk","year":"2017","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3747\/co.23.3487","article-title":"A user\u2019s guide to cannabinoid therapies in oncology","volume":"23","author":"Maida","year":"2016","journal-title":"Curr. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Young","year":"1990","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: State of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid Ligands Targeting TRP Channels","volume":"11","author":"Muller","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/15384101.2020.1742952","article-title":"Cannabinoids as anticancer therapeutic agents","volume":"19","author":"Kovalchuk","year":"2020","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-X","article-title":"Hashish\u2014I: The structure of Cannabidiol","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104822","DOI":"10.1016\/j.phrs.2020.104822","article-title":"Cannabis sativa: Much more beyond Delta(9)-tetrahydrocannabinol","volume":"157","author":"Alves","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tomko, A.M., Whynot, E.G., Ellis, L.D., and Dupre, D.J. (2020). Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis. Cancers, 12.","DOI":"10.3390\/cancers12071985"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2826.2008.01670.x","article-title":"Multiple Roles for the Endocannabinoid System During the Earliest Stages of Life: Pre- and Postnatal Development","volume":"20","author":"Fride","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0024-3205(99)00295-7","article-title":"Role of endocannabinoids in brain development","volume":"65","author":"Berrendero","year":"1999","journal-title":"Life Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1046\/j.1460-9568.2003.02599.x","article-title":"Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain","volume":"17","author":"Mato","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/j.1460-9568.2008.06484.x","article-title":"The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro","volume":"28","author":"Vitalis","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.conb.2008.08.007","article-title":"Wiring and firing neuronal networks: Endocannabinoids take center stage","volume":"18","author":"Harkany","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejphar.2004.07.033","article-title":"The endocannabinoid-CB1 receptor system in pre- and postnatal life","volume":"500","author":"Fride","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/55.3.597","article-title":"Antineoplastic Activity of Cannabinoids","volume":"55","author":"Munson","year":"1975","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cam4.1312","article-title":"The current state and future perspectives of cannabinoids in cancer biology","volume":"7","author":"Sledzinski","year":"2018","journal-title":"Cancer Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.18632\/oncotarget.26983","article-title":"The heterogeneity and complexity of Cannabis extracts as antitumor agents","volume":"10","author":"Baram","year":"2019","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3892\/ijo.2017.4022","article-title":"Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration","volume":"51","author":"Scott","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1300\/J175v01n03_08","article-title":"Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?","volume":"1","author":"McPartland","year":"2001","journal-title":"J. Cannabis Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tips.2013.03.003","article-title":"The endocannabinoid signaling system in cancer","volume":"34","author":"Pisanti","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pnpbp.2015.05.010","article-title":"The use of cannabinoids as anticancer agents","volume":"64","author":"Velasco","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.3747\/co.23.3080","article-title":"Anticancer mechanisms of cannabinoids","volume":"23","author":"Velasco","year":"2016","journal-title":"Curr. Oncol. (Tor. Ont.)"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.2147\/OTT.S106944","article-title":"Endocannabinoid system as a regulator of tumor cell malignancy\u2014Biological pathways and clinical significance","volume":"9","author":"Pyszniak","year":"2016","journal-title":"Oncotargets Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lfs.2015.12.053","article-title":"Ligands for cannabinoid receptors, promising anticancer agents","volume":"146","author":"Nikan","year":"2016","journal-title":"Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/nop\/npw027","article-title":"The use of cannabis in supportive care and treatment of brain tumor","volume":"4","author":"Likar","year":"2017","journal-title":"Neuro-Oncol. Pract."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2012.1476","article-title":"Cannabinoid-associated cell death mechanisms in tumor models (Review)","volume":"41","author":"Calvaruso","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/hep.27686","article-title":"Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms","volume":"61","author":"Mukhopadhyay","year":"2014","journal-title":"Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1158\/0008-5472.CAN-11-0924","article-title":"PAX3-FOXO1 Induces Cannabinoid Receptor 1 to Enhance Cell Invasion and Metastasis","volume":"71","author":"Marshall","year":"2011","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-03-3720","article-title":"Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE\/ADAM17)-mediated transactivation of the epidermal growth factor receptor","volume":"64","author":"Hart","year":"2004","journal-title":"Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Freund, P., Porpaczy, E.A., Le, T., Gruber, M., Pausz, C., Staber, P., Jager, U., and Vanura, K. (2016). Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156693"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbadis.2007.05.006","article-title":"TRP channels in cancer","volume":"1772","author":"Prevarskaya","year":"2007","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_57","first-page":"636","article-title":"The Yin and Yang of Cannabis-a systematic review of human neuroimaging evidence of the differential effects of delta-9-tetrahydrocannabinol and cannabidiol","volume":"6","author":"Gunasekera","year":"2020","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e20171818","DOI":"10.1542\/peds.2017-1818","article-title":"Medical Cannabinoids in Children and Adolescents: A Systematic Review","volume":"140","author":"Wong","year":"2017","journal-title":"Pediatrics"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e26826","DOI":"10.1002\/pbc.26826","article-title":"Medical marijuana in pediatric oncology: A review of the evidence and implications for practice","volume":"65","author":"Ananth","year":"2017","journal-title":"Pediatric Blood Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.yebeh.2019.07.007","article-title":"The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study","volume":"98","author":"Mitelpunkt","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/dmcn.14548","article-title":"Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: A randomized controlled trial","volume":"62","author":"Fairhurst","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40263-019-00624-4","article-title":"Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy","volume":"33","author":"Wheless","year":"2019","journal-title":"CNS Drugs"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1212\/WNL.0000000000005254","article-title":"Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome","volume":"90","author":"Devinsky","year":"2018","journal-title":"Neurology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","article-title":"Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial","volume":"77","author":"Miller","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/epi.14670","article-title":"Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study","volume":"60","author":"Thiele","year":"2019","journal-title":"Epilepsia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial","volume":"78","author":"Thiele","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13229-021-00420-2","article-title":"Cannabinoid treatment for autism: A proof-of-concept randomized trial","volume":"12","author":"Aran","year":"2021","journal-title":"Mol. Autism"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: An open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/epi.14628","article-title":"Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial","volume":"60","author":"Devinsky","year":"2019","journal-title":"Epilepsia"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.yebeh.2013.08.037","article-title":"Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy","volume":"29","author":"Porter","year":"2013","journal-title":"Epilepsy Behav."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Silvestro, S., Mammana, S., Cavalli, E., Bramanti, P., and Mazzon, E. (2019). Use of cannabidiol in the treatment of epilepsy: Efficacy and security in clinical trials. Molecules, 24.","DOI":"10.3390\/molecules24081459"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-020-00621-9","article-title":"Cannabinoids for the Treatment of Epilepsy: A Review","volume":"22","author":"Galan","year":"2020","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-018-0882-y","article-title":"Cannabis for the Treatment of Epilepsy: An Update","volume":"18","author":"Gaston","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia (Copenhagen)"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ejpn.2016.07.021","article-title":"Effective treatment of spasticity using dronabinol in pediatric palliative care","volume":"20","author":"Kuhlen","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_79","first-page":"3503","article-title":"Cannabis use in pediatric cancer patients: What are they reading? A review of the online literature","volume":"28","author":"Yeung","year":"2020","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Andradas, C., Truong, A., Byrne, J., and Endersby, R. (2021). The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology. Cancers, 13.","DOI":"10.3390\/cancers13010157"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacotherapy"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1476-5381.2008.00048.x","article-title":"Emerging strategies for exploiting cannabinoid receptor agonists as medicines","volume":"156","author":"Pertwee","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_83","first-page":"40","article-title":"Cannabidiol use in children","volume":"36","author":"Schuman","year":"2019","journal-title":"Contemp. Pediatrics"},{"key":"ref_84","first-page":"CD007786","article-title":"Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood","volume":"2","author":"Phillips","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/adc.61.5.502","article-title":"Nabilone: An alternative antiemetic for cancer chemotherapy","volume":"61","author":"Dalzell","year":"1986","journal-title":"Arch. Dis. Child."},{"key":"ref_86","first-page":"946","article-title":"Nabilone Versus Prochlorperazine for Control of Cancer Chemotherapy-Induced Emesis in Children: A Double-Blind, Crossover Trial","volume":"79","author":"Chan","year":"1987","journal-title":"Pediatrics"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5694\/j.1326-5377.1979.tb127271.x","article-title":"Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydro-cannabinol","volume":"2","author":"Ekert","year":"1979","journal-title":"Med. J. Aust."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/0024-3205(95)00194-B","article-title":"An efficient new cannabinoid antiemetic in pediatric oncology","volume":"56","author":"Abrahamov","year":"1995","journal-title":"Life Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/08880018.2019.1630537","article-title":"Medical marijuana use for pediatric oncology patients: Single institution experience","volume":"36","author":"Ofir","year":"2019","journal-title":"Pediatric Hematol. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00381-016-3243-7","article-title":"Spontaneous involution of pediatric low-grade gliomas: High expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system","volume":"32","author":"Sredni","year":"2016","journal-title":"Child\u2019s Nerv. Syst."},{"key":"ref_91","first-page":"161","article-title":"Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors","volume":"1137","author":"Grajkowska","year":"2006","journal-title":"Brain Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.3747\/co.23.2893","article-title":"In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma","volume":"23","author":"Fisher","year":"2016","journal-title":"Curr. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.18632\/oncotarget.26534","article-title":"Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells","volume":"10","author":"Alharris","year":"2019","journal-title":"Oncotarget"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejphar.2014.11.023","article-title":"AM404 inhibits NFAT and NF-kappa B signaling pathways and impairs migration and invasiveness of neuroblastoma cells","volume":"746","author":"Caballero","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/mol.106.023937","article-title":"Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression","volume":"70","author":"McKallip","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.leukres.2005.01.014","article-title":"Targeting cannabinoid receptors to treat leukemia: Role of cross-talk between extrinsic and intrinsic pathways in Delta(9)-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells","volume":"29","author":"Lombard","year":"2005","journal-title":"Leuk. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1158\/1541-7786.MCR-05-0193","article-title":"Delta 9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of bad to mitochondria","volume":"4","author":"Jia","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.yexcr.2006.03.009","article-title":"The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway","volume":"312","author":"Herrera","year":"2006","journal-title":"Exp. Cell Res."},{"key":"ref_99","first-page":"12","article-title":"Cannabinoid CP55940 selectively induces apoptosis in Jurkat cells and in ex vivo T-cell acute lymphoblastic leukemia through H2O2 signaling mechanism","volume":"95","author":"Fox","year":"2020","journal-title":"Leuk. Res."},{"key":"ref_100","first-page":"1","article-title":"Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia","volume":"10","author":"Pottosin","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1159\/000356446","article-title":"Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation","volume":"6","author":"Singh","year":"2013","journal-title":"Case Rep. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00381-011-1410-4","article-title":"Spontaneous regression of septum pellucidum\/forniceal pilocytic astrocytomas\u2014possible role of Cannabis inhalation","volume":"27","author":"Foroughi","year":"2011","journal-title":"Child\u2019s Nerv. Syst."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1158\/1535-7163.MCT-08-1147","article-title":"Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma","volume":"8","author":"Oesch","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.1073\/pnas.0409641102","article-title":"Altering Cannabinoid Signaling during Development Disrupts Neuronal Activity","volume":"102","author":"Bernard","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/npp.2017.143","article-title":"The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development","volume":"43","author":"Meyer","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_106","first-page":"1922","article-title":"Adverse Effects of Cannabis on Adolescent Brain Development: A Longitudinal Study","volume":"27","author":"Camchong","year":"2017","journal-title":"Cereb. Cortex (New York N.Y. 1991)"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e20170559","DOI":"10.1542\/peds.2017-0559","article-title":"Provider Perspectives on Use of Medical Marijuana in Children with Cancer","volume":"141","author":"Ananth","year":"2018","journal-title":"Pediatrics"},{"key":"ref_108","first-page":"89","article-title":"The Role of Cannabinoids in the Treatment of Children with Cancer","volume":"19","author":"Golan","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40263-018-0550-4","article-title":"Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System","volume":"32","author":"Schonhofen","year":"2018","journal-title":"CNS Drugs"},{"key":"ref_110","unstructured":"Government of Canada (2021, July 20). Cannabis Market Data: Overview, Available online: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/research-data\/market.html."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/3\/359\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:20Z","timestamp":1760135840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/3\/359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":110,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ph15030359"],"URL":"https:\/\/doi.org\/10.3390\/ph15030359","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}